Click on image to view larger version.

Figure 6 Systemic infusion of BQ-788 (300 nmol/min), a selective ET_B-receptor antagonist, in healthy subjects increases systemic vascular resistance (SVR) and decreases heart rate (HR), cardiac index (CI) and stroke volume index (SVI). There was no significant change in systemic arterial blood pressure (MAP). (Modified from [206]).